OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Brent Stockwell

2 Projects | 1 Researchers | $364,329 Invested

2018

Trustees of Columbia University in the City of New York

Brent Stockwell, PhD

Evaluation and development of optimized PDI modulators for AD

  • Funding Amount: $120,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Oxidative Stress
  • Status: Closed

2015

Trustees of Columbia University in the City of New York

Brent Stockwell, PhD

Protein disulfide isomerase (PDI) inhibitors as neuroprotective agents for Alzheimer's disease.

  • Funding Amount: $244,329
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Oxidative Stress
  • Status: Closed